Physician profile
Jason R Bailey
NPI 1629366232
$51,119.19
in general payments reported to CMS, 2019-2025
38 companies · $5,988 in 2025
The $5,988 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $4,354 · 2021: $7,943 · 2022: $8,629 · 2023: $7,523 · 2024: $6,274 · 2025: $5,988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Food and Beverage: $7,547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,237.82 |
| Food and Beverage | $7,547.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $18,491.55 | 2019-2025 | Infinity, Ortholoc 2 Lapifuse, Ortholoc 3di |
| Arthrex, INC. | $11,258.28 | 2019-2025 | |
| Crossroads Extremity Systems, LLC | $6,773.98 | 2019-2021 | |
| Conetic Solutions, INC. | $2,806.09 | 2020-2025 | |
| Medline Industries LP | $2,677.66 | 2020-2025 | |
| Vilex LLC | $1,448.69 | 2023 | |
| Zimmer Biomet Holdings, INC. | $1,343.12 | 2020-2023 | Nextremity General Instrument, Natural Nail |
| Musculoskeletal Transplant Foundation INC. | $1,095.06 | 2019-2023 | |
| Restor3d, INC. | $1,061.47 | 2023-2025 | |
| Depuy Synthes Sales INC. | $742.45 | 2019-2022 | |
| Rsw Medical Company, INC. | $528.14 | 2019 | |
| International Life Sciences | $521.14 | 2023-2024 | Flexband |
| Organogenesis INC. | $425.80 | 2019-2025 | Puraply, Affinity, Puraply Am |
| Integra Lifesciences Corporation | $388.72 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $314.74 | 2019-2025 | Grafix Pl, Collagenase Santyl |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $167.91 | 2022 | |
| Orthofix Medical, INC. | $110.57 | 2019-2025 | Galaxy Fixation System, Tl-Hex Truelok Hexapod System, Physio-Stim |
| Kci USA, INC. | $110.05 | 2019-2021 | |
| Ossio INC | $107.44 | 2022 | |
| Arthrosurface Incorporated | $104.28 | 2020 | |
| Linvatec Corporation | $100.18 | 2025 | Biobrace 23mm |
| Novastep INC. | $55.89 | 2024 | Nexis |
| Nvision Biomedical Technologies, INC. | $48.82 | 2024 | Trigon |
| Medshape, INC. | $45.86 | 2024 | Dynanail Helix, Washer, 15 Mm |
| Kerecis Limited | $42.78 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Osiris Therapeutics INC. | $41.55 | 2019 | |
| Convatec INC. | $40.08 | 2025 | |
| Misonix INC | $37.07 | 2020 | |
| Lifenet Health | $32.49 | 2024 | Theragenesis Wound Matrix |
| Kowa Pharmaceuticals America, INC. | $28.14 | 2022-2023 | Seglentis |
| Paratek Pharmaceuticals, INC. | $26.98 | 2024 | Nuzyra |
| Medtronic, INC. | $25.22 | 2022 | |
| Treace Medical Concepts, INC. | $24.45 | 2022 | |
| Abbvie INC. | $24.16 | 2023 | Dalvance |
| Solventum Corporation | $21.23 | 2025 | Activ.A.C., 3m Cavilon |
| Horizon Therapeutics Plc | $17.48 | 2021 | |
| Heron Therapeutics, INC. | $15.00 | 2024 | Zynrelef |
| Baudax Bio INC. | $14.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.